PACK IN HAND · ONE-PAGE CHECK
Medicine pack check sheet
Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.
Published record starting point
- Record display name
- DETROL LA
- Generic name / active ingredient
- tolterodine tartrate extended-release capsules
- Dosage-form class
- Tolterodine tartrate extended-release oral capsules: 2 mg or 4 mg per capsule; the label says to swallow whole with liquid; not an immediate-release tolterodine tablet, fesoterodine extended-release tablet or another bladder medicine
- Route
- Oral
- Record reviewed
- 2026-08-29
Copy from the pack in hand
Source-linked reading points
- 2 mg and 4 mg are labelled amounts per capsule, while 30 is the bottle count. Although two 2 mg numbers add to 4 mg, that does not permit self-assembling capsules, changing an amount, replacing a 4 mg product, making up a dose or copying another person's prescription.
- Swallow the capsule whole with liquid. The label does not turn capsule appearance, lack of a score or ‘extended release’ into permission to open, chew, crush, divide or sprinkle it. For swallowing difficulty, take the exact pack and prescription to a pharmacist or prescriber for an appropriate plan.
- Dry mouth, constipation, abdominal pain, blurred vision, dizziness or drowsiness are important label adverse-effect cues. Older adults, people with cognitive impairment or fall risk, and those using sleeping, allergy, nausea, bladder or other anticholinergic medicines need priority review of the complete medicine list.
- Urinary retention, gastric retention and uncontrolled narrow-angle glaucoma are labelled contraindications. Gastrointestinal obstruction or reduced motility, myasthenia gravis, liver or kidney impairment and a history of QT prolongation also need to be disclosed.
Reviewed presentation examples — compare every field
- Tolterodine tartrate 2 mg per capsule; 30-capsule bottle; this package record has a marketing end date of 31 Jul 2026NDC 58151-103-93
- Tolterodine tartrate 4 mg per capsule; 30-capsule bottle; this package record has a marketing end date of 31 Jul 2026NDC 58151-104-93